Search Results

You are looking at 81 - 90 of 563 items for :

  • Refine by Access: All x
Clear All
Full access

CLO24-079: Results From Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion Dependent (RBC-TD) Non-del(5q) Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents (ESAs)

Yazan Madanat, Michael R. Savona, Mikkael A. Sekeres, Uwe Platzbecker, Valeria Santini, Pierre Fenaux, Maria Diez-Campelo, David Valcárcel, Tymara Berry, Souria Dougherty, Sheetal Shah, Libo Sun, Ying Wan, Fei Huang, Shyamala Navada, Rami S. Komrokji, and Amer M. Zeidan

secondary endpoints included 8- and 24-wk TI, hematologic improvement-erythroid (HI-E), duration of TI, and safety. Cytogenetic response (IWG 2006), VAF changes, and patient-reported fatigue were exploratory endpoints. Results: At baseline, median age was

Full access

Letter to the Editor: Chicken Noodle Soup (Capsule) for the Soul?

Lindsey A. Kluck and Ronald S. Go

Re: Sriram Yennurajalingam, Nizar M. Tannir, Janet L. Williams, et al. A Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients with Advanced Cancer. J Natl Compr Canc Netw 2017

Full access

Benefits Associated with an Early Hemoglobin Response to Epoetin Alfa Therapy in the Treatment of Chemotherapy-Related Anemia

Susana M. Campos, Mei Sheng Duh, Patrick Lefebvre, and James Rosberg

. Factors influencing quality of life in cancer patents: anemia and fatigue . Semin Oncol 1998 ; 25 : 43 – 46 . 4 Curt GA . Impact of fatigue on quality of life in oncology patients . Semin Hematol 2000 ; 37 : 14 – 17 . 5 Sobrero

Full access

Erratum

;21[5]: 473–479.e4 ; doi: 10.6004/jnccn.2022.7101 ), Figure 1 was printed incorrectly. The starting points of the lines for G3 fatigue; G2 nausea; and G1 anemia should have been positioned farther to the right. The figure is printed correctly below

Full access

CLO20-061: A Meta-Analysis on the Safety of Panobinostat Compared to Eltozumab and Ixazomib for the Treatment of Multiple Myeloma

Nishanth Thalambedu, Waqas Ullah, Ammar Ashfaq, Yasir Khan, Mishal Shaukat, and Qian Zhang

.11) Figure 1 . Paobinostat had a significantly lower risk of lymphopenia (OR 0.25 95% CI 0.15-0.42, p=<0.0001) Panobinostat was however, associated with two times more risk of anemia (OR 2.82 95% CI 1.82-4.38, p=<0.0001), fatigue (OR 2.36 95% CI 1.64-3.38, p

Full access

NCCN News

needs and priorities. November marked the publication of a new NCCN Guidelines for Patients: Palliative Care , part of an ongoing expansion of supportive care resources. The new NCCN Guidelines for Patients: Fatigue and Cancer has also been published

Full access

Relationship Between Hemoglobin Levels and Quality of Life During Radiation Therapy Plus Concomitant or Sequential Chemotherapy in Patients With Cancer and Anemia Treated With Epoetin Alfa

Daniel Shasha, Pierre Cremieux, and Louis Harrison

patients undergoing radiation therapy . Semin Oncol 2001 ; 28 ( suppl 8 ): 54 – 59 . 4 Irvine D Vincent L Graydon JE . The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy: A comparison

Full access

CLO22-088: Phase II Trial of Trifluridine/Tipiracil in Combination With Irinotecan in Advanced Biliary Tract Cancers (BTCs)

Sri Harsha Tella, Jaclynn Wessling, Foster Nathan, Shi Qian, Tran Nguyen, Robert McWillimas, Alberts Steven, Minetta Liu, Mitesh Borad, Wen Wee Ma, Mindy Hartgers, Leslie Washburn, Fruth Briant, Martin Fernandezzapico, Tara L Hogenson, Henry Pitot, Zhaohui Jin, and Amit Mahipal

(11%), fatigue (7%), and diarrhea (7%). 9 out of 27 (33%) and 14/27 (52%) had dose reductions secondary to AEs (cytopenias and fatigue) for trifluridine/tipiracil and irinotecan, respectively and 1 patient discontinued the therapy due to adverse events

Full access

QIM23-129: Impact of the COVID Pandemic on Oncology Education, Mentorship, and Networking—A National Survey

Zachary Veitch, Jessica L. Conway, Giulio Di Diodato, and Jennifer Croke

worked in academia (71.2%). Oncologists attending ≥7+ CME/CPD events/year declined -23.5% for pre- (56.1%) vs pandemic (32.6%), with top reasons for not attending including work (66.7%) or home (59.1%) commitments, video fatigue (61.4%), and burnout (39

Full access

HSR23-089: Patient Reported Quality of Life (QoL) Among Adults Admitted for Oncology Care in Abu Dhabi, United Arab Emirates (UAE)

Derek Dale Ang Bayquen and Aaron Thrush

global score of 42 (33, 58). Patients functioned lowest in role and social domains and highest in cognitive. The most problematic symptoms were pain and fatigue, and least problematic were diarrhea and financial difficulties. The 40–49 and 50–59 age group